Report summary

Notifier

Name of person with notification obligation

Anders Bladh

Reason for notification

Closely associated

Yes

Person discharging managerial responsibilities

Anders Lennart Bladh, Ribbskottet

Position

Member of the Board of Directors

Initial notification

Yes

Amendment

Details of amendment

Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor

Name of issuer

XSpray Pharma AB (publ)

Issuer´s LEI code

549300NGRQCNZ3X4L157

Details of transaction

Type of financial instrument	Financial instrument	ISIN code	Nature of transaction	Linked to the exercise of a share option programme	Volume	Unit	Price per unit	Currency code	Transaction date	Place of the transaction
BTA	XSpray Pharma AB BTA	SE0028355099	Acquisition		16,594	Quantity	26.49	SEK	04/05/2026	NASDAQ STOCKHOLM AB

Aggregation

Financial instrument	ISIN code	Nature of transaction	Transaction date	Place of the transaction	Volume	Weighted average price
XSpray Pharma AB BTA	SE0028355099	Acquisition	04/05/2026	NASDAQ STOCKHOLM AB	16,594 (Quantity)	26.49 SEK
				Total:	16,594

<< Back